# Prostate Cancer Program - 07

> **NIH NIH P30** · JOHNS HOPKINS UNIVERSITY · 2021 · $55,386

## Abstract

ABSTRACT
The focus of the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Prostate Cancer (PC) Program is
the development of new approaches to prostate cancer detection, diagnosis and treatment. The Program
emphasizes a comprehensive basic and translational research approach to prostate cancer, embodied in three
interactive Program scientific goals: 1) understanding the molecular genetics and epidemiology of prostate
cancer, 2) elucidating the molecular underpinnings of prostate cancer, and 3) discovering and developing new
prostate cancer therapies. Through advances in each of these goals, the Program has translated several
discoveries into high-impact preclinical and clinical studies.
The PC Program includes 30 Program members from four departments at the Johns Hopkins University
School of Medicine (Oncology, Pathology, Radiation Oncology and Molecular Radiation Sciences, and
Urology) and one from Howard University. The Program also closely interacts with the Cancer Immunology
Program, the Cancer Molecular and Functional Imaging Program, and the Cancer Prevention and Control
Program at the Johns Hopkins Bloomberg School of Public Health (Epidemiology).
The research portfolio of the Program, which encompasses nearly all prostate cancer research at Johns
Hopkins, receives support from the National Cancer Institute and other peer-reviewed funding sources,
including a Prostate Cancer SPORE. The Program members have funding of $20.3 million total costs
annually, of which $13.8 million total costs is peer-reviewed. Twenty-one Program members (70%) have
peer-reviewed funding. Program trainees, both pre- and Postdoctoral, are supported by training grants from
the SKCCC, the Department of Pharmacology and Molecular Sciences, and the Cellular and Molecular
Medicine Program.
Collectively, the PC Program membership has published 599 publications. The Program is highly interactive,
with 245 (41%) Intra-Programmatic, 219 (37%) Inter-Programmatic and 238 (40%) multi-institutional
collaborations.

## Key facts

- **NIH application ID:** 10135913
- **Project number:** 5P30CA006973-58
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** KENNETH J. PIENTA
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $55,386
- **Award type:** 5
- **Project period:** 1997-05-07 → 2022-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10135913

## Citation

> US National Institutes of Health, RePORTER application 10135913, Prostate Cancer Program - 07 (5P30CA006973-58). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10135913. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*